Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 1, 1999, Pages 103-104

  Garratty, George ^a   Leger, Regina M ^b   Arndt, Patricia A ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b NONE

Author keywords

Cefotetan; Cephalosporins; Drug induced hemolytic anemia

Indexed keywords

ANTIBODY; CEFOTETAN; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HUMAN CELL; OBSTETRICS; PRIORITY JOURNAL;

EID: 0032815981     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70443-6     Document Type: Article

References (3)

1. 1. Garratty G. Immune cytopenia associated with antibiotics. Trans Med Rev 1993;7:255-67.
2. 2. Gallagher NI, Schergen AK, Sokol-Anderson ML, et al. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion 1992;32:266-8.
3. 3. Mohammed S, Knoll S, van Amburg A III, Mennes PA. Cefotetan-induced hemolytic anemia causing severe hypophosphatemia. Am J Hematol 1994;46:369-70.